Predicting poor outcome in perforated peptic ulcer disease

Australian and New Zealand Journal of Surgery

Volumn 67, Issue 11, 1997, Pages 792-795

  Evans, J P ^a   Smith, R ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Peptic ulcer; Perforated ulcer; Prognosis

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; STEROID;

ADULT; AGED; ARTICLE; EMERGENCY SURGERY; FEMALE; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PEPTIC ULCER; RISK ASSESSMENT; TREATMENT OUTCOME; ULCER PERFORATION;

EID: 0030696888     PISSN: 00048682     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-2197.1997.tb04582.x     Document Type: Article

References (23)

1. Stabile BE, Passaro E Jr. Duodenal ulcer: A disease in evolution. Curr. Probl. Surg. 1984; 21: 6-17.
2. McConnell DB, Baba GC, Deveney CW. Changes in surgical treatment of peptic ulcer disease within a Veterans Hospital in the 1970s and the 1980s. Arch. Surg. 1989; 124: 1164-7.
3. Walt R, Katschinski B, Logan R, Ashley J, Langman M. Rising frequency of ulcer perforation in elderly people in the United Kingdom. Lancet 1986; 2: 489-92.
4. Bliss DW, Stabile BE. The impact of ulcerogenic drugs on surgery for the treatment of peptic ulcer disease. Arch. Surg. 1991; 126: 609-12.
5. Christensen A, Bousfield R, Christiansen J. Incidence of perforated and bleeding peptic ulcers before and after the introduction of H2-receptor antagonists. Ann. Surg. 1988; 207: 4-6.
6. Cocks JR. Perforated peptic ulcer - the changing scene. Dig. Dis. 1992; 10: 10-16.
7. Boey J, Choi SKY, Alagaratnam TT, Poon A. Risk stratification in perforated duodenal ulcers. Ann. Surg. 1987; 205: 22-6.
8. Langman MJS. Epidemiologic evidence on the association between peptic ulceration and antiinflammatory drug use. Gastroenterology 1989; 96: 640-6.
9. Graham DY, Smith JL. Gastroduodenal complications of chronic NSAID therapy. Am. J. Gastroenterol. 1988; 83: 1081-4.
10. Green SB, Gail MH, Byar DP. Steroids and peptic ulcer. N. Engl. J. Med. 1976; 294: 473-6.
11. Messer J, Sacks HS, Reitman D, Chalmers TC. Corticosteroids do cause peptic ulcer disease. Gastroenterology 1982; 82: 1130.
12. Collier DStJ, Pain JA. Non-steroidal anti-inflammatory drugs and peptic ulcer perforation. Gut 1985; 26: 359-63.
13. Dayton MT, Kleckner SC, Brown DK. Peptic ulcer perforation associated with steroid use. Arch. Surg. 1987; 122: 376-80.
14. Backgaard N, Lawaetz O, Poulsen PE. Simple closure or definitive surgery for perforated duodenal ulcer. Scand. J. Gastroenterol. 1979; 14: 17-20.
15. Jordan PH Jr. Proximal cell vagotomy without drainage for treatment of perforated duodenal ulcer. Gastroenterology 1982; 83: 179-83.
16. Boey J, Wong J, Ong GB. A prospective study of operative risk factors in perforated duodenal ulcers. Ann. Surg. 1982; 195: 265-9.
17. Bulut OB, Rasmussen C, Fischer A. Acute surgical treatment of complicated peptic ulcers with special reference to the elderly. World J. Surg. 1996; 20: 574-7.
18. Ricci JL, Turnbull ADM. Spontaneous gastroduodenal perforation in cancer patients receiving cytotoxic therapy. J. Surg. Oncol. 1989; 41: 219-21.
19. Ferrara JJ, Martin EW, Carey LC. Morbidity of emergency operations in patients with metastatic cancer receiving chemotherapy. Surgery 1982; 92: 605-9.
20. al-Assi MT, Graham DY. Peptic ulcer disease, Helicobacter pylori, and the surgeon: Changing of the guard. Curr. Opin. Gen. Surg. 1994; 120-4.
21. Kozol RA. Surgery for peptic ulcer in the Helicobacter pylori era. Arch. Surg. 1995; 130: 1040-1.
22. Debongnie JC, Wibin E, Timmermans M, Mairesse J, Dekoninck X. Are perforated gastroduodenal ulcers related to Helicobacter pylori infection? Acta Gastroenterol. Belg. 1995; 58: 208-12.
23. Sebastian M, Chandran VP, Elashaal YI, Sim AJ. Helicobacter pylori infection in perforated ulcer disease. Br. J. Surg. 1995; 82: 360-2.